RoMaDent
ActiveSummary
RoMaDent has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €790,509 and a net result of €338,639. Equity is growing by about 45% per year across the filed financial years. Its solvency ranks better than 85% of 20,620 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
02-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Liquidity doublescurrent ratio 11.14
Current ratio from 5.57 to 11.14; short-term debt falls from €91,990 to €51,524.
22-09
NBB filing
Annual accounts filed
financial year 2024 · micro format · 53 days late
2024
31-12
Financial
Highest result from 2020 to 2025net €391,170 ▲21.8%
Operating result €517,662, net result €391,170, both a record.
31-12
Financial
Liquidity more than 5 timescurrent ratio 5.57
Current ratio from 1.02 to 5.57; short-term debt falls from €396,325 to €91,990.
31-12
Financial
Equity above €500,000equity €701,870 ▲126%
A profit in every financial year since 2020 builds equity to €701,870.
22-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
13-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-12
Financial
Equity above €200,000equity €389,515 ▲159%
A profit in every financial year since 2020 builds equity to €389,515.
28-09
NBB filing
Annual accounts filed
financial year 2021 · micro format · 59 days late
2021
31-12
Financial
Equity above €150,000equity €150,571 ▲144%
A profit in every financial year since 2020 builds equity to €150,571.
01-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.